ArticlePLoS pathogens2026
Hijacking of host PCNA by circovirus replication-associated protein to recruit POLD1 drives viral DNA replication and is inhibited by R428.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circoviruses are the smallest known mammalian viruses with a single-stranded circular genome, whose replication capacity is highly dependent on host factors. Although the virus-encoded replication-associated protein (Rep/Rep') plays a critical role in circovirus DNA replication, it lacks polymerase activity. Here, we uncovered a mechanism by which circoviruses hijack the host proliferating cell nuclear antigen (PCNA) via their Rep to recruit POLD1, the catalytic subunit of host DNA polymerase δ, thereby driving viral DNA synthesis. POLD1 was identified to be the major polymerase in the replication of circovirus DNA, and the virus infection promoted POLD1 expression. Further, it had been found that the Rep of Circoviruses bound to host sliding clamp protein PCNA to indirectly recruit POLD1 to viral replication centers, and the N-terminal motif LIXXG of Rep and the C-terminal motif NXNXK of PCNA were identified to be corresponding conservative binding sites. As PCV2 is the most clinically significant circovirus, a small-molecule drug R428 was screened to effectively block the binding between PCV2 Rep and porcine PCNA. R428 could significantly suppress the formation of the Rep/PCNA complex in cells, and effectively suppress PCV2 replication and alleviate PCV2 infection-induced tissue damage in mice and piglets. In conclusion, we elucidated the novel mechanism by which circoviruses hijack host PCNA-POLD1 to facilitate their DNA replication via Rep, and identified R428 as a potential anti-PCV2 agent for the prevention and control of circovirus-associated diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.